Literature DB >> 28366118

Enhancing Clients' Communication Regarding Goals for Using Psychiatric Medications.

Patricia E Deegan1, Elizabeth Carpenter-Song1, Robert E Drake1, John A Naslund1, Alison Luciano1, Shari L Hutchison1.   

Abstract

OBJECTIVE: Discordance between psychiatric care providers' and clients' goals for medication treatment is prevalent and is a barrier to person-centered care. Power statements-short self-advocacy statements prepared by clients in response to a two-part template-offer a novel approach to help clients clarify and communicate their personal goals for using psychiatric medications. This study described the power statement method and examined a sample of power statements to understand clients' goals for medication treatment.
METHODS: More than 17,000 adults with serious mental illness at 69 public mental health clinics had the option to develop power statements by using a Web application located in the clinic waiting areas. A database query determined the percentage of clients who entered power statements into the Web application. The authors examined textual data from a random sample of 300 power statements by using content analysis.
RESULTS: Nearly 14,000 (79%) clients developed power statements. Of the 277 statements in the sample deemed appropriate for content analysis, 272 statements had responses to the first part of the template and 230 had responses to the second part. Clients wanted psychiatric medications to help control symptoms in the service of improving functioning. Common goals for taking psychiatric medications (N=230 statements) were to enhance relationships (51%), well-being (32%), self-sufficiency (23%), employment (19%), hobbies (15%), and self-improvement (10%).
CONCLUSIONS: People with serious mental illness typically viewed medications as a means to pursue meaningful life goals. Power statements appear to be a simple and scalable technique to enhance clients' communication of their goals for psychiatric medication treatment.

Entities:  

Keywords:  Psychopharmacology/psychosocial aspects, Recovery, psychotropic medication; computer decision support; qualitative study; recovery; shared decision making

Mesh:

Substances:

Year:  2017        PMID: 28366118     DOI: 10.1176/appi.ps.201600418

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  6 in total

Review 1.  Digital technology for health promotion: opportunities to address excess mortality in persons living with severe mental disorders.

Authors:  John A Naslund; Kelly A Aschbrenner
Journal:  Evid Based Ment Health       Date:  2018-12-17

2.  Simulations Test Impact Of Education, Employment, And Income Improvements On Minority Patients With Mental Illness.

Authors:  Margarita Alegria; Robert E Drake; Hyeon-Ah Kang; Justin Metcalfe; Jingchen Liu; Karissa DiMarzio; Naomi Ali
Journal:  Health Aff (Millwood)       Date:  2017-06-01       Impact factor: 6.301

3.  The Future of Peer Support in Digital Psychiatry: Promise, Progress, and Opportunities.

Authors:  Karen L Fortuna; Maria Venegas; Emre Umucu; George Mois; Robert Walker; Jessica M Brooks
Journal:  Curr Treat Options Psychiatry       Date:  2019-06-20

4.  Implementation and Use of a Client-Facing Web-Based Shared Decision-Making System (MyCHOIS-CommonGround) in Two Specialty Mental Health Clinics.

Authors:  Molly Finnerty; Elizabeth Austin; Qingxian Chen; Deborah Layman; Edith Kealey; Daisy Ng-Mak; Krithika Rajagopalan; Kimberly Hoagwood
Journal:  Community Ment Health J       Date:  2018-10-13

5.  Quantifying the treatment goals of people recently diagnosed with schizophrenia using best-worst scaling.

Authors:  John Fp Bridges; Kathleen Beusterien; Stephan Heres; Pedro Such; Joaquín Sánchez-Covisa; Anna-Greta Nylander; Elcie Chan; Anne de Jong-Laird
Journal:  Patient Prefer Adherence       Date:  2018-01-04       Impact factor: 2.711

6.  Shared Decision Making in Primary Care Based Depression Treatment: Communication and Decision-Making Preferences Among an Underserved Patient Population.

Authors:  Elizabeth B Matthews; Margot Savoy; Anuradha Paranjape; Diana Washington; Treanna Hackney; Danielle Galis; Yaara Zisman-Ilani
Journal:  Front Psychiatry       Date:  2021-07-12       Impact factor: 4.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.